Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to Fas-induced apoptosis

被引:76
作者
Stel, Alia J.
ten Cate, Bram
Jacobs, Susan
Kok, Jan Willem
Spierings, Diana C. J.
Dondorff, Monica
Helfrich, Wijnand
Kluin-Nelemans, Hanneke C.
de Leij, Lou F. A. H.
Withoff, Sebo
Kroesen, Bart Jan
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Sect Med Biol,Lab Tumor Immunol, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Membrane Cell Biol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9713 GZ Groningen, Netherlands
[4] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA
关键词
D O I
10.4049/jimmunol.178.4.2287
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ab binding to CD20 has been shown to induce apoptosis in B cells. In this study, we demonstrate that rituximab sensitizes lymphoma B cells to Fas-induced apoptosis in a caspase-8-dependent manner. To elucidate the mechanism by which Rituximab affects Fas-mediated cell death, we investigated rituximab-induced signaling and apoptosis pathways. Rituximab-induced apoptosis involved the death receptor pathway and proceeded in a caspase-8-dependent manner. Ectopic overexpression of FLIP (the physiological inhibitor of the death receptor pathway) or application of zIETD-fmk (specific inhibitor of caspase-8, the initiator-caspase of the death receptor pathway) both specifically reduced rituximab-induced apoptosis in Ramos B cells. Blocking the death receptor ligands Fas ligand or TRAIL, using neutralizing Abs, did not inhibit apoptosis, implying that a direct death receptor/ligand interaction is not involved in CD20-mediated cell death. Instead, we hypothesized that rituximab-induced apoptosis involves membrane clustering of Fas molecules that leads to formation of the death-inducing signaling complex (DISC) and downstream activation of the death receptor pathway. Indeed, Fas coimmune precipitation experiments showed that, upon CD20-cross-linking, Fas-associated death domain protein (FADD) and caspase-8 were recruited into the DISC. Additionally, rituximab induced CD20 and Fas translocation to raft-like domains on the cell surface. Further analysis revealed that, upon stimulation with rituximab, Fas, caspase-8, and FADD were found in sucrose-gradient raft fractions together with CD20. In conclusion, in this study, we present evidence for the involvement of the death receptor pathway in rituximab-induced apoptosis of Ramos B cells with concomitant sensitization of these cells to Fas-mediated apoptosis via Fas multimerization and recruitment of caspase-8 and FADD to the DISC.
引用
收藏
页码:2287 / 2295
页数:9
相关论文
共 43 条
[41]   Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis [J].
Vega, MI ;
Huerta-Yepez, S ;
Jazirehi, AR ;
Garban, H ;
Bonavida, B .
ONCOGENE, 2005, 24 (55) :8114-8127
[42]   Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-κB activity:: Role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively [J].
Vega, MI ;
Jazirehi, AR ;
Huerta-Yepez, S ;
Bonavida, B .
JOURNAL OF IMMUNOLOGY, 2005, 175 (04) :2174-2183
[43]   Rituximab inhibits p38 MAPK activity in 2F7 BNHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance [J].
Vega, MI ;
Huerta-Yepaz, S ;
Garban, H ;
Jazirehi, A ;
Emmanouilides, C ;
Bonavida, B .
ONCOGENE, 2004, 23 (20) :3530-3540